Your session is about to expire
← Back to Search
Latin Dance & Exercise Programs for Aging (CEREBRO Trial)
N/A
Waitlist Available
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-intervention through study completion, an average of 1 year
Awards & highlights
CEREBRO Trial Summary
This trial aims to reduce risk of Alzheimer's disease in older Latinos by creating evidence-based Spanish-language, Latin dance and physical activity programs that can be adapted for remote delivery.
Who is the study for?
This trial is for Latinos over 65 with mild cognitive impairment, who speak Spanish and exercise less than once a week. They should not need daily caregiving, have severe health issues like uncontrolled heart disease or diabetes, recent fractures, pacemakers, stroke history, or severe COPD.Check my eligibility
What is being tested?
The study tests two home-based physical activity programs designed to reduce Alzheimer's risk and improve life quality in older Latinos: BAILAMOS™ @home/en casa (a Latin dance program) and ¡En Forma y Fuerte! @home/en casa (an adapted fitness program). Participants will be randomly assigned to one of these programs.See study design
What are the potential side effects?
Since the interventions involve physical activity programs tailored for older adults with arthritis and cognitive decline risks, side effects may include typical exercise-related discomforts such as muscle soreness or fatigue.
CEREBRO Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ pre-intervention through study completion, an average of 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-intervention through study completion, an average of 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Feasibility - Intervention adherence
Denture Retention
Secondary outcome measures
Cognition
Device-assessed Physical activity
Health Related Quality of life
+2 moreCEREBRO Trial Design
2Treatment groups
Experimental Treatment
Group I: ¡En Forma y Fuerte! @home/en casaExperimental Treatment1 Intervention
¡En Forma y Fuerte! @home/en casa is an exercise and health education program designed to improve arthritis-related outcomes. The classes will meet two times per week for 90 min each for 12 weeks. Each class session consists of 60 min of exercise (flexibility, aerobics and strength training) and 30 minutes of health education using group problem solving based on SCT.
Group II: BAILAMOS™ @home/en casaExperimental Treatment1 Intervention
The BAILAMOS™ @home/en casa dance program is provided twice weekly for 24 weeks. Each month a new dance style is introduced by a professional dance instructor.
Find a Location
Who is running the clinical trial?
University of Illinois at ChicagoLead Sponsor
607 Previous Clinical Trials
1,559,255 Total Patients Enrolled
1 Trials studying Aging
35 Patients Enrolled for Aging
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I need help from someone else for my daily activities.I have had a stroke before.I have severe COPD.I will not leave the country for more than 2 weeks in the next 6 months.I am older than 65.I have a bone that is currently healing or has recently healed from a fracture.I have uncontrolled heart disease or diabetes.
Research Study Groups:
This trial has the following groups:- Group 1: ¡En Forma y Fuerte! @home/en casa
- Group 2: BAILAMOS™ @home/en casa
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are participants being accepted for this research endeavor at present?
"As per the information provided on clinicaltrials.gov, this research initiative is no longer recruiting participants. This investigation was initially posted in December 1st 2022 and its most recent edit happened on October 18th of the same year. Even though recruitment has concluded for this study, there are still 246 other trials actively seeking patients at present time."
Answered by AI
What aims is this medical experiment hoping to fulfill?
"The primary outcome evaluated over a one year period is the feasibility of intervention adherence. Secondary outcomes include Health Related Quality of Life (SF-12 Scale), Self-Report Physical Activity (CHAMPS Questionnaire for Older Adults) and Cognition (NIHTB-CB Neuropsychological Measures)."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger